The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Measurement of cognitive dysfunction in the early stages of Alzheimer's disease (AD) has been well studied and there are many objective tests in use for this purpose. However, with the exception of clinical rating scales, such as the Clinical Dementia Rating Scale, Global Deterioration Scale, and Functional Assessment Staging, there are few objective measures of cognition in the more advanced stages of AD. Given a renewed interest in potential AD therapies, objective measures of mental functioning are needed to adequately assess change in more advanced AD patients. As part of an effort by the NIA-Alzheimer's Disease Cooperative Study to evaluate new measures of efficacy for their utility in treatment studies, the Severe Impairment Battery (SIB) was examined in a 1-year evaluation of change across a wide range of AD severity. The data suggest that the SIB is a reliable and valid measure of progression, particularly in persons with moderate to severe AD. The SIB may therefore be a useful outcome measure in clinical trials that include patients with more advanced stages of AD.

Cortisol responses to cholinergic drugs in Alzheimer's disease.

Patients with Alzheimer's disease participated in a trial of two sessions in which they received physostigmine and neostigmine in a double-blind crossover design. Most of these patients subsequently participated in a scopolamine vs saline double-blind crossover trial using a similar design. Physostigmine increased plasma cortisol relative to neostigmine, with the greatest difference at time points greater than 90 min post drug oral administration. Physostigmine also significantly decreased plasma cholinesterase (ChE). There was a significant positive correlation between the effects of physostigmine on increasing cortisol and decreasing ChE; there was no correlation between the increase in cortisol of cholinesterase inhibitor following neostigmine administration, but neither of these chemical parameters is related to the drug's effects on cognitive functioning.

The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity.

In an examination of 34 southern African SAT-type foot-and-mouth disease viruses, all but 1 attained satisfactory levels of infectivity within 6 passages in rolled BHK21 monolayer cell cultures. However, there were marked differences between adapted viruses with respect to the mass of immunogen (146S material) produced. Several isolates which consistently produced levels greater than or equal to 2 micrograms/ml were identified. In cross neutralization tests using post-vaccinal sera, SAT-1 and SAT-2 isolates showed considerable diversity and none of the viruses tested would be expected to produce a broad-spectrum response if incorporated into a vaccine. On the other hand, when 2 of the SAT-2 isolates were incorporated into the same vaccine a distinctly broader response resulted.

Bacteriologic survey of black rhinoceros (Diceros bicornis).

A bacteriological survey was carried out on 30 black rhinoceros (Diceros bicornis) of which 23 were newly captured and seven were captive. A beta haemolytic Streptococcus, group L was found in skin lesions and various wounds, causing septicaemia and death in two animals. Staphylococcus aureus was found in 3 rhinoceros, and caused the death of one. The bacteria isolated often proved resistant to penicillin. Streptomycin is recommended for treatment. Sixteen other bacteria sp. were isolated, and apart from a Salmonella sp. none were considered to be specific pathogens.

Experience with monovalent and bivalent influenza vaccines in Canada 1976.

Laboratory examination of vaccines from four manufacturing companies and prepared with A/New Jersey/8/76 and A/Victoria/3/75 strains (clinical results, cf. these proceedings, pp. 267-272). When diluting the concentrated suspensions of vaccine, loss of activity can be avoided by adding a small amount of Tween 80 to the diluent.

Penicillinase-producing Neisseria gonorrhoeae.

Repeated failure of penicillin G treatment in a man with gonorrhoeal urethritis prompted penicillin sensitivity testing of the responsible strain of Neisseria gonorrhoeae. Disc diffusion sensitivity testing showed complete resistance to 10 mug of penicillin G. The organism produced penicillinase.